These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial. Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193 [TBL] [Abstract][Full Text] [Related]
33. Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients? Johnson DW; Nicol DL; Purdie DM; Preston JM; Brown AM; Hawley CM; Campbell SB; Wall D; Griffin AD; Isbel NM Transplantation; 2002 Apr; 73(7):1158-63. PubMed ID: 11965051 [TBL] [Abstract][Full Text] [Related]
34. Mycophenolate mofetil (MMF) in heart transplantation: rejection prevention and treatment. Renlund DG; Gopinathan SK; Kfoury AG; Taylor DO Clin Transplant; 1996 Feb; 10(1 Pt 2):136-9. PubMed ID: 8680051 [TBL] [Abstract][Full Text] [Related]
35. Single-center analysis of the incidence of acute rejection in cadaveric renal allograft recipients induced with low-dose OKT3 with and without mycophenolate mofetil. Abdulbaki A; el-Ghoroury M; Provenzano R; Oh H Transplant Proc; 1999 Aug; 31(5):2112-3. PubMed ID: 10455985 [No Abstract] [Full Text] [Related]
36. [Use of mycophenolate mofetil (MMF) in kidney transplantation: results of a single center trial]. Pastural M; Barrou B; Golmard JL; Gorichon-Radideau E; Manighetti J; Ourahma S; Benalia H; Mouquet C; Chatelain C; Bitker MO Prog Urol; 1999 Feb; 9(1):19-25. PubMed ID: 10212949 [TBL] [Abstract][Full Text] [Related]
37. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study. Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582 [TBL] [Abstract][Full Text] [Related]
38. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus. Hunt SA Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892 [TBL] [Abstract][Full Text] [Related]
39. Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid. Bystryn JC Arch Dermatol; 2008 Jul; 144(7):946. PubMed ID: 18645153 [No Abstract] [Full Text] [Related]
40. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat. Vu MD; Qi S; Xu D; Wu J; Peng J; Daloze P; Sehgal S; Leduc B; Chen H Transplantation; 1998 Dec; 66(12):1575-80. PubMed ID: 9884242 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]